The Verge talks to nference's Venky Soundararajan, whose team says users wait about two months to tell doctors, and two thirds of records show no documented result.
Recap by typeshit. Full story at The Verge.
An explainer on how GLP-1 drugs act on reward and craving in the brain, and the research testing them against alcohol, nicotine and other substance use.
Dr Alo, a cardiologist, says he is following the cardiovascular data on these drugs closely and that it is shifting how heart disease is treated.
50:28
DOWNSIZED looks at why appetite and food noise can creep back late in the weekly cycle, and what that may say about whether a GLP-1 is still working.
Avi Roy points to trial data on drugs like Ozempic, including a 16-week study of 73 people where milkshake ratings barely changed despite reduced appetite.
New WHO childhood obesity guidance cites unknown effects on growth and mental health, while Novo, Lilly, AstraZeneca and Pfizer keep testing the drugs in kids.
UW Medicine breaks down the peptide therapies now showing up everywhere and what they are.
Loading…